21.98 +0.17 (0.78%)
IPXL
| Trade IPXL now with |
|
Stock Details
Last Trade:21.98 Change:+0.17 (0.78%) Prev Close:21.81 Open: 21.79 Days Range:21.58 – 22.47 52 Week Range: 14.46 - 28.75 Volume:757435 P/E: 26.48EPS:0.83
View AllRecent Alerts 02/08/12
Recent Alert on 02/06/12 at 9:29am
Canaccord Genuity on Life Sciences/Specialty Pharmaceuticals: Q4/11 Preview: Post-2012 Message a Growing Focus: WPI and IPXL Top Ideas
Canaccord Genuity on Life Sciences/Specialty Pharmaceuticals: Q4/11 Preview: Post-2012 Message a Growing Focus: WPI and IPXL Top Ideas
Canaccord Genuity on Life Sciences/Specialty Pharmaceuticals: Q4/11 preview: post-2012 message a growing focus; WPI and IPXL top ideas Analyst, Randall Stanicky, said, "Calendar Q4 earnings will be a non-event for most – but other catalysts... Read More
Recent Alert on 02/02/12 at 8:53am
Canaccord Genuity Reiterates a 'Buy' on Impax Labs (IPXL); Raising Estimates on Deal Announcement; Sentiment Starting to Shift
Canaccord Genuity Reiterates a 'Buy' on Impax Labs (IPXL); Raising Estimates on Deal Announcement; Sentiment Starting to Shift
Recent Alert on 02/02/12 at 8:06am
Needham & Company on Impax Labs (IPXL): Not a Strategic Game-Change but Zomig Offsets SG&A Ramp and Provides Short-Term EPS Boost
Needham & Company on Impax Labs (IPXL): Not a Strategic Game-Change but Zomig Offsets SG&A Ramp and Provides Short-Term EPS Boost
Recent Alert on 02/01/12 at 8:07am
Impax (IPXL) Unit Licenses Zomig Rights in U.S. from AstraZeneca (AZN); Updates FY12 Outlook
Impax (IPXL) Unit Licenses Zomig Rights in U.S. from AstraZeneca (AZN); Updates FY12 Outlook
View AllRecent Press Releases
No Recent Press Releases Available